Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    RFC3
Show Display Options
Rank Status Study
1 Completed Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma
Condition: Non Hodgkin Lymphoma
Intervention: Drug: Rituximab Fludarabine Cyclophosphamide
2 Completed Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Condition: Head and Neck Cancer
Intervention: Drug: Pralatrexate With Vitamin B12 and Folic Acid
3 Recruiting A Study of MabThera (Rituximab) in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia And Favorable Somatic Status
Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: cyclophosphamide;   Drug: fludarabine;   Drug: rituximab [MabThera]
4 Active, not recruiting A Study to Compare Mabthera (Rituximab), Fludarabine and Cyclophosphamide to Mabthera and Chlorambucil in Patients With Chronic Lymphocytic Leukemia and Unfavourable Somatic Status
Condition: Lymphocytic Leukemia, Chronic
Interventions: Drug: chlorambucil;   Drug: cyclophosphamide;   Drug: fludarabine;   Drug: rituximab [MabThera]
5 Active, not recruiting Early Detection of Autism Spectrum Disorder in Children
Condition: Autism Spectrum Disorder
Intervention:
6 Completed A Study of Pemetrexed Plus Oxaliplatin as First Line Therapy in Advanced Gastric Carcinoma
Condition: Advanced Gastric Carcinoma
Interventions: Drug: pemetrexed;   Drug: oxaliplatin
7 Active, not recruiting Vascular Evaluation for Revascularization: Defining the Indications for Coronary Therapy: A Pilot Study
Condition: Coronary Artery Disease
Interventions: Device: FFR and VH-IVUS;   Device: IVUS and FFR
8 Recruiting Autologous Stem Cells Transplantation in Patients With Idiopathic and Drug Induced Premature Ovarian Failure
Condition: Premature Ovarian Failure
Intervention: Biological: Biological: Stem Cells
9 Completed Retaane® in Age-Related Macular Degeneration
Condition: Age Related Macular Degeneration
Intervention: Drug: juxtascleral depot injection of Retaane
10 Recruiting Testicular Injection of Autologous Stem Cells for Treatment of Patients With Azoospermia
Condition: Azoospermia
Intervention: Biological: Stem Cells
11 Completed Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention: Other: Surface expression of functional biomarkers of the NK cell

Indicates status has not been verified in more than two years